CRISPR

19 statements across 11 episodes · 16 bullish · 0 bearish · 7 people on the record · first statement Dec 15, 2017 by Jorge Conde · said 19 times in 12 episodes since 2018 · across every show →

Mentions by year

brought up most by Jorge Conde (5), Sonal Chokshi (4), George Church (3), Andy Tran (2), Tony Robbins (1), Jim Collins (1), Frank Chen (1), Daphne Koller (1)

tap a year for its mentions
001052010201820192020202120222023episodesmentions
0510201820192020202120222023episodes it came up in
0015210201820192020202120222023episodesmentions per episode
2023 2 mentions in 2 episodes 1 per episode
2019 16 mentions in 9 episodes 2 per episode
2018 1 mention in 1 episode

every mention, scene by scene, with the transcript →

Everything said about CRISPR, oldest first

Dec 15, 2017 neutral
Assertion Supported
Conde: Scientists used CRISPR to encode and retrieve digital video in DNA
“What scientists were able to do is they were able to take this video, the pixels from this video, and using CRISPR can coax a bacterial cell to ingest the information and store it in its DNA. And on the right, what you're seeing Is scientists' ability to retri…”
Jorge Conde Dec 15, 2017 ▶ 21:35 Challenges in Healthcare Innovation
Mar 23, 2018 bullish
Insight
Conde: CRISPR and new tools make genetic engineering a true discipline
“And now I think with the advent of things like CRISPR and things that companies like Asimov are doing where they're actually making DNA a design medium. I think it's, we're actually starting to make genetic engineering be an engineer discipline.”
Jorge Conde Mar 23, 2018 ▶ 6:19 Pande & Conde: When (and How) Biology Becomes Engineering
Dec 22, 2018 bullish
Prediction Not checkable as stated
Precise editing and better delivery will expand gene therapy applications
“So as we advance our ability to deliver gene therapy, as we advance our ability to actually very precisely edit the genes, and only the genes that we need to edit, gene therapy will become applicable to a far broader range of diseases, not just limited to thos…”
Jorge Conde Dec 22, 2018 ▶ 12:36 Programming Medicine
Jan 2, 2019 bullish
Prediction Not checkable as stated
Smith: Technologies Like CRISPR And Driverless Cars Cannot Be Suppressed
“On this point, you can't stop technology. You can't suppress it. These things are coming. CRISPR is coming to design your baby someday. Driverless cars are coming.”
Noah Smith Jan 2, 2019 ▶ 37:46 a16z Podcast | Adjusting to Trade... and Innovation
Jan 2, 2019 bullish
Prediction Not checkable as stated
Conde: Engineering biology will produce tools even more powerful than CRISPR
“As we move biology more and more into an engineer-based discipline, I think we're going to see more powerful modalities like CRISPR.”
Jorge Conde Jan 2, 2019 ▶ 16:58 a16z Podcast | Taking the Pulse on Bio
Jan 2, 2019 positive
Assertion Not checkable as stated
Conde: CRISPR became an indispensable drug discovery tool in just years
“CRISPR is a concept barely registered just a few years ago, and now it's an indispensable tool for drug discovery, for, actually, for understanding biology, as we've seen the cycles of iteration in biology accelerate.”
Jorge Conde Jan 2, 2019 ▶ 16:45 a16z Podcast | Taking the Pulse on Bio
Jan 2, 2019 bullish
Prediction Not checkable as stated
Lowe: Non-therapeutic CRISPR applications like diagnostics are just beginning
“I also think we're going to see a lot of interesting things in the non-therapeutic CRISPR space. So in a therapeutic CRISPR side, there are a bunch of public companies that are going directly after using CRISPR to cure disease. I think it's just the beginning …”
Jeffrey Lowe Jan 2, 2019 ▶ 28:07 a16z Podcast | Taking the Pulse on Bio
Jan 2, 2019 positive
Insight
Conde: CRISPR and Asimov are turning genetic engineering into true design
“And now I think with the advent of things like CRISPR and things that companies like Asimov are doing where they're actually making DNA a design medium. I think it's, we're actually starting to make genetic engineering be an engineer discipline, but I think th…”
Jorge Conde Jan 2, 2019 ▶ 6:43 a16z Podcast | When (and How) Biology Becomes Engineering
Apr 1, 2019 positive
Opinion
Church: Targeting HIV via CRISPR is more justifiable than Mendelian diseases
“Yeah, I think that we want an example of a disease that is very common, and most of the gene therapies are rare, whether they're editing or not, and we want something that's very serious, and certainly HIV falls in that category, So it struck me as a plausibly…”
George Church Apr 1, 2019 ▶ 9:54 a16z Podcast | What's in the Water at the George Church Lab?
Apr 1, 2019 neutral
Assertion Supported
Church: Embryo selection avoids Mendelian diseases without CRISPR editing
“Ignoring the fact that if you're in an IVF, PGD clinic anyway. To do your CRISPR editing of your Mendelian disease, you could just do selection for most of these things.”
George Church Apr 1, 2019 ▶ 9:16 a16z Podcast | What's in the Water at the George Church Lab?
Apr 1, 2019
Insight
Church: CRISPR is gene damaging rather than precision editing
“So what CRISPR does well, it's often described as editing. It really is damaging, is what it is. It's not really that good at precision editing.”
George Church Apr 1, 2019 ▶ 3:16 a16z Podcast | What's in the Water at the George Church Lab?
Oct 5, 2019 positive
Assertion Supported
Tran: CRISPR cut gene editing engineering timelines from months to days
“Compared to old tools, engineering was cut down from a few months to a matter of weeks or days.”
Andy Tran Oct 5, 2019 ▶ 4:56 CRISPR 2.0 and the Future of Gene Therapies
Oct 5, 2019 positive
Assertion Supported
Tran: Alternative Cas nucleases offer advantages in size and precision over Cas9
“Some Cas nucleases are much smaller, come from less immunogenic strains, are more precise, or have new mechanisms altogether.”
Andy Tran Oct 5, 2019 ▶ 6:08 CRISPR 2.0 and the Future of Gene Therapies
Oct 5, 2019 bullish
Prediction Not checkable as stated
Tran: Metagenomic mining will uncover genome editing systems beyond CRISPR
“As we continue to mine new metagenomic data of new species, it's not crazy to think that perhaps even CRISPR itself is by no means the final frontier of genome engineering.”
Andy Tran Oct 5, 2019 ▶ 18:46 CRISPR 2.0 and the Future of Gene Therapies
Oct 5, 2019 positive
Insight
Tran: CRISPR is evolving into a cellular search engine platform
“Instead of just this pair of molecular scissors that everyone talks about, the biggest recent shift in the field is this push towards making CRISPR a search engine platform of the cell.”
Andy Tran Oct 5, 2019 ▶ 6:21 CRISPR 2.0 and the Future of Gene Therapies
Oct 5, 2019 positive
Assertion Supported
Tran: CRISPR tools can directly target and edit RNA bases
“We can even now directly target and edit RNA bases, opening up the entire field of transcriptomic editing.”
Andy Tran Oct 5, 2019 ▶ 7:41 CRISPR 2.0 and the Future of Gene Therapies
Sep 25, 2023 positive
Assertion Open · timeframe Sep 2026
Koller: Insitro runs genome-wide CRISPR screens in two weeks
“When they're all in a pool, you eliminate all of those artifacts, and all of a sudden you have the ability to measure a genome-wide CRISPR screen, basically, so, 20,000 genes in the genome, all modifying the same cellular background in the same dish with a dif…”
Daphne Koller Sep 25, 2023 ▶ 6:07 Digital Biology with insitro's Daphne Koller
Dec 12, 2023 positive
Assertion Supported
CRISPR progressed from initial discovery to FDA approval in just 10 years
“It's barely been 10 years since the concept of CRISPR was discovered and described in the scientific literature. So we went from the initial discovery of CRISPR as a potential use as a medicine, all the way to an approval in just over 10 years. That is lightni…”
Jorge Conde Dec 12, 2023 ▶ 15:30 Big Ideas in 2024: Programming Medicine’s Final Frontier with Jorge Conde
Aug 1, 2024 positive
Assertion Supported
GSK made AI core to its strategy via in-house functional genomics
“They're fully investing in the things I thought were very important at the time, which was, you know, these large genetic databases coming online and functional genomics. So he was way ahead in the, in sort of the thinking about CRISPR and like the gene pertur…”
Kim Branson Aug 1, 2024 ▶ 5:32 AI in Pharmaceutical R&D with Kim Branson
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.